Suppr超能文献

用于发现I型甘露糖苷酶抑制剂的功能化高甘露糖特异性凝集素

Functionalized High Mannose-Specific Lectins for the Discovery of Type I Mannosidase Inhibitors.

作者信息

Kurhade Suresh E, Weiner Jack D, Gao Fei Philip, Farrell Mark P

机构信息

Department of Medicinal Chemistry, The University of Kansas, 2034 Becker Drive, Lawrence, KS, 66047, USA.

Protein Production Group, The University of Kansas, 2034 Becker Drive, Lawrence, KS, 66047, USA.

出版信息

Angew Chem Int Ed Engl. 2021 May 25;60(22):12313-12318. doi: 10.1002/anie.202101249. Epub 2021 Apr 26.

Abstract

An engineered cyanovirin-N homologue that exhibits specificity for high mannose N-glycans has been constructed to aid type I α 1,2-mannosidase inhibitor discovery and development. Engineering the lectins C-terminus permitted facile functionalization with fluorophores via a sortase and click strategy. The resulting lectin constructs exhibit specificity for cells presenting high mannose N-glycans. Importantly, these lectin constructs can also be applied to specifically assess changes in cell surface glycosylation induced by type I mannosidase inhibitors. Testing the utility of these lectin constructs led to the discovery of type I mannosidase inhibitors with nanomolar potency. Cumulatively, these findings reveal the specificity and utility of the functionalized cyanovirin-N homologue constructs, and highlight their potential in analytical contexts that require high mannose-specific lectins.

摘要

为了辅助I型α 1,2-甘露糖苷酶抑制剂的发现与开发,构建了一种对高甘露糖型N-聚糖具有特异性的工程化氰病毒素-N同源物。对凝集素的C端进行工程改造,使其能够通过分选酶和点击策略方便地与荧光团进行功能化修饰。所得的凝集素构建体对呈现高甘露糖型N-聚糖的细胞具有特异性。重要的是,这些凝集素构建体还可用于特异性评估I型甘露糖苷酶抑制剂诱导的细胞表面糖基化变化。对这些凝集素构建体的实用性进行测试,发现了具有纳摩尔效力的I型甘露糖苷酶抑制剂。总体而言,这些发现揭示了功能化氰病毒素-N同源物构建体的特异性和实用性,并突出了它们在需要高甘露糖特异性凝集素的分析环境中的潜力。

相似文献

2
Lectin Drug Conjugates Targeting High Mannose N-Glycans.糖肽药物偶联物靶向高甘露糖 N-聚糖。
Chembiochem. 2022 Oct 6;23(19):e202200266. doi: 10.1002/cbic.202200266. Epub 2022 Jul 27.

本文引用的文献

1
Broadening the scope of sortagging.拓宽分选标记的范围。
RSC Adv. 2019 Feb 6;9(9):4700-4721. doi: 10.1039/c8ra06705h. eCollection 2019 Feb 5.
7
Inhibition of MAN2A1 Enhances the Immune Response to Anti-PD-L1 in Human Tumors.抑制 MAN2A1 增强了抗 PD-L1 治疗人类肿瘤的免疫反应。
Clin Cancer Res. 2020 Nov 15;26(22):5990-6002. doi: 10.1158/1078-0432.CCR-20-0778. Epub 2020 Jul 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验